Where does Biora Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biora Therapeutics, Inc. ranks #16,637 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biora Therapeutics, Inc. hold?

Biora Therapeutics, Inc. holds 17 US utility patents granted between 2022 and 2025, spanning 13 technology areas.

What is Biora Therapeutics, Inc.'s Innovation Score?

Biora Therapeutics, Inc. has an Innovation Score of 54.8 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biora Therapeutics, Inc. focus on?

Biora Therapeutics, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 13 patents, ranking #1,747 of 7,163 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Biora Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Biora Therapeutics, Inc..

What does claim depth mean for Biora Therapeutics, Inc.'s patents?

Biora Therapeutics, Inc.'s patents average 20.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biora Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biora Therapeutics, Inc.

USPTO PatentsView assignee record - 17 granted patents across 13 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biora ranks #16,637 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 13 technology areas.

#16,637
of 49,997 US assignees by volume: Top 7%
by Innovation Score (54.8/100): 20.1
avg claims per patent

USPTO PatentsView assignee plate

Corpus R16637 · US Corporation #16,637 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 17 grants
MID-PACK #16,637/49,997
PHOTO-FINISH Bioaxial SAS
CPC-FOCUS A61K · 13 areas
INNOV-PAR 54.8/100
CLAIMS-DENSE 20.1 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Bioaxial SAS (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biora’s 54.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (18%) Velocity 20.0 pts (37%) Breadth 12.7 pts (23%) Claim depth 12.0 pts (22%)

Qualcomm Incorporated · highest

85
Biora Therapeutics · this assignee

55
3D Lighting… · lowest

7

What this shows Biora's Innovation Score is 54.8/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biora?

Each dot is one of Biora’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biora’s own 20.1 claims/patent is ABOVE the 15.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biora vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biora's grants concentrate

Biora Therapeutics, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 76.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (7 grants) versus a trough of 4 in 2022. By volume, Biora sits between BioLineRx Ltd. and Bradken Resources Pty Limited.

Biora's three-year grant acceleration

Biora Therapeutics, Inc. shows 16 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Biolinerx

17
Bioxcel Therapeut…

17
Bioaxial SAS

17
Biological Innova…

17
Blackbird Technol…

17
Blue Planet Syste…

17
Bluefin Labs

17
Bradken Resources…

17
Biora Therapeutics ◀

17

What this shows Biora holds 17 patents at rank #16,651, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biora

By rank, the assignees closest to #16,651 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Biora's primary technology class.

Biora's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Biora Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	4	23.5%
2023	5	29.4%
2024	7	41.2%
2025partial year	1	5.9%

Which technologies does Biora Therapeutics, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 11

A61B - DIAGNOSIS; SURGERY; Identification 11

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

C07K - Peptides 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

H04B - Transmission 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biora Therapeutics, Inc.'s patent record in context - here's where to go next.

Biora Therapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 76.5% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #16,637 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biora Therapeutics, Inc. against BioLineRx Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.